Literature DB >> 2538360

Y1 and Y2 receptors for neuropeptide Y.

S P Sheikh1, R Håkanson, T W Schwartz.   

Abstract

By using monoiodinated radioligands of both intact neuropeptide Y (NPY) and of a long C-terminal fragment, NPY13-36, two subtypes of binding sites, which differ in affinity and specificity, have been characterized. The Y1 type of binding site, characterized on a human neuroblastoma cell line, MC-IXC, and a rat pheochromocytoma cell line, PC-12, binds NPY with a dissociation constant (Kd) of a few nanomolar but does not bind NPY13-36. The Y2 type of binding site, characterized on porcine hippocampal membranes and on another human neuroblastoma cell line, SMS-MSN, is of higher affinity and binds both NPY and NPY13-36. None of the binding sites distinguish between NPY and the homologous peptide YY (PYY). It is concluded that NPY/PYY-binding sites occur in two subtypes which may represent two types of physiological receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538360     DOI: 10.1016/0014-5793(89)80223-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

Review 1.  Current prospects and challenges for epilepsy gene therapy.

Authors:  Marc S Weinberg; Thomas J McCown
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

2.  Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene related peptide.

Authors:  T C Westfall; S P Han; M Knuepfer; J Martin; X L Chen; K del Valle; A Ciarleglio; L Naes
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

3.  Effects of the neuropeptide YY1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo .

Authors:  R E Malmström; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

4.  Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia.

Authors:  X Zhang; T Shi; K Holmberg; M Landry; W Huang; H Xiao; G Ju; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney.

Authors:  J S Price; A J Kenny; N S Huskisson; M J Brown
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

6.  Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.

Authors:  H Gicquiaux; M Tschöpl; H N Doods; B Bucher
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  Innervation of the mink pineal gland with neuropeptide Y (NPY)-containing nerve fibers. An experimental immunohistochemical study.

Authors:  M Møller; J D Mikkelsen; L Martinet
Journal:  Cell Tissue Res       Date:  1990-09       Impact factor: 5.249

8.  Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.

Authors:  P deS Senanayake; J Denker; E L Bravo; R M Graham
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat.

Authors:  D Bleakman; N L Harrison; W F Colmers; R J Miller
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

10.  Peptide YY selectively stimulates expression of the colonocytic phenotype.

Authors:  S A Sgambati; G A Turowski; M D Basson
Journal:  J Gastrointest Surg       Date:  1997 Nov-Dec       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.